Bullseye explores, celebrates and invests in American Ingenuity, managing a portfolio of 35-50 publicly-traded US equities with significant runway for growth. These are dynamic, US companies propelling the world forward across multiple industries. Frequent focus sectors include Energy, Health and Technology. Every pick shares three defining attributes: great story, compelling data, timely catalyst.
Bullseye Brief Members receive the following:
  1. Bullseye Brief - Actionable new stock pick every week
  2. Bullseye View - What’s happening in key markets
  3. Bullseye Now - News, catalysts and trades in our stocks
  4. Bullseye Podcast - Meet the people driving American Ingenuity
  5. Bullseye Access - Email Adam directly with questions/comments

Adam Johnson

Adam Johnson anchored several business programs at Bloomberg Television over five years, interviewing CEOs, heads of state, and Nobel laureates. His daily video investment blog, Insight and Action was sponsored by a major U.S. lender. Previously he managed global risk assets for ING Furman Selz and Louis Dreyfus, trading oil futures, listed equities and equity options. Adam began his career at Merrill Lynch with a degree in economics at Princeton.


Enjoy a 45-day trial of Bullseye Brief for only $45!
After 45 days, the account will automatically switch to a $295 quarterly subscription.
You can cancel at any time.

Click Here

The 22nd Century… Today

Unrivaled Innovation At Scale

  • For months I held off buying the world’s largest IPO because I wanted more evidence of its ability to grow
  • The evidence has become apparent as accelerating revenue drives profitability far sooner than anticipated
  • This company is driving how the world thinks, communicates and operates in ways that have no equal

Catch of the Century – The world watched in awe as Elon Musk’s Starship rocket descended from space last week in a perfectly controlled ballet, returning delicately to the arms of its forty-story cradle at Starbase Texas. The engineering is incredible, but what it facilitates is even more impressive. Starship is a reusable platform capable of lifting 100 tons and 100 people simultaneously into orbit. It’s the world’s only way to rapidly deploy entire satellite communication constellations into orbit, beam real-time AI/compute anywhere in the world, build/supply a future moon base, and launch manned exploration to Mars. Critically, profitability is happening far sooner than I thought possible. Q3 marked the company’s first quarter in the black, and earnings could rise 12-fold over the next 12 months.


November 21, 2026

Read More

The Moneyball of Cancer

Beating Tumors With Data

  • Cancer treatment is moving from one-size-fits-all chemo to targeted therapy for individual patient genomes
  • Customized drugs produce better individual results and growing database improves overall success rates
  • Global pharmaceutical leaders are paying for access to the database in order to speed drug development

Moneyball – The 2002 Oakland A’s won the same number of games as the New York Yankees with one-third the payroll for one reason: Data analytics. Manager Billy Beane ignored gut feel and instead trusted the numbers, as Michael Lewis’ best-selling Moneyball so brilliantly outlined… ultimately spawning a box office blockbuster with Brad Pitt and prompting every MLB team to create its own Analytics Dept. Twenty-four years later, cancer treatment is having its own Moneyball moment. Thanks to data collected from thousands of cancer patients over a decade, oncologists are able to design customized drugs that target specific mutations driving tumor formation. Like smart bombs programmed to hit specific targets, these drugs find and deactivate errant genes, regardless of where they are in the body. It’s a complex and global effort no single hospital network could tackle, but one Chicago-based company is leading the charge. It’s medicine’s AI-enabled cancer leader, and this week’s new pick.


November 21, 2026

Read More

Assessing Anthropic

Is the IPO a Buy?

  • Anthropic’s 14x increase in revenue and $130B in cash pave the way for operating profitability by 2028
  • The company’s five-year compute bill totals $637B but is supported by ratable long-term contracts
  • Strong-handed partners own one-third of the company and are not likely to sell shares after the lock-up

Game Changer – I began using Anthropic’s Claude last spring, after a Columbia Business School professor who’d invited me to address his students gave me a demo. He instructed Claude to define my American Ingenuity paradigm, then identify companies I’d overlooked and generate reports written in my style. The results were staggering, and I signed up immediately. My experience is not unique, which explains why quarterly revenues have increased 1,400% to $16B in twelve months. With all the hand-wringing over the cost of developing AI, Anthropic is in a league of its own. This ultra-hot IPO will likely turn a profit this year, and depending on how bankers price the offering, I may buy it.


November 21, 2026

Read More
  • Login to your Account

  • Login

img-2

10

As in Google pays $10M to bankrupt Spirit Airlines’ conservator for 20+ years of emails, maintenance data, HR records, etc.
#ToTrainGeminiOnAirlineOps

69

As in 69% of tech industry leaders expect AI will be the primary driver of corporate growth and productivity, according the WSJ.
#AndTheOther31??

154

As in an estimated $154B in illicit criminal flows passed through crypto exchanges from 2021 to 2025 (Univ. of Texas).
#BringBackCLARITYAct

img-1

“My ideal investing is stuff that looks a little crazy now and in 3-5 years is obvious.”
– LinkedIn Co-founder Reid Hoffman
#AmericanIngenuity

“Jensen Huang has been a tremendous leader for the industry.”
– AMD CEO Lisa Su
#WhatAMess

“I think next year sometime we’ll have a robotics model that works out of the box on all kinds of skills and tasks.”
– Genesis AI Co-founder Zhou Xian
#AnotherCaliforniaStartupToWatch